BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8080736)

  • 1. Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
    Jäger W; Kissing A; Cilaci S; Melsheimer R; Lang N
    Br J Cancer; 1994 Sep; 70(3):493-5. PubMed ID: 8080736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 125 as an indicator of pleural metastases in breast cancer patients.
    Krämer S; Raff U; Jäger W; Lang N
    Anticancer Res; 1996; 16(5B):3165-8. PubMed ID: 8920785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 is an indicator for pleural metastases in breast cancer.
    Krämer S; Jäger W; Lang N
    Anticancer Res; 1997; 17(4B):2967-70. PubMed ID: 9329577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor marker CA 15-3 in breast cancer patients.
    Fejzić H; Mujagić S; Azabagić S; Burina M
    Acta Med Acad; 2015; 44(1):39-46. PubMed ID: 26062696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of bone and liver metastases in breast cancer comparing tumor markers and imaging techniques.
    Zanco P; Rota G; Sportiello V; Borsato N; Ferlin G
    Int J Biol Markers; 1989; 4(2):103-5. PubMed ID: 2768888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 15-3 in patients with locoregional and metastatic breast carcinoma.
    Geraghty JG; Coveney EC; Sherry F; O'Higgins NJ; Duffy MJ
    Cancer; 1992 Dec; 70(12):2831-4. PubMed ID: 1451063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of tumour marker CA 15-3 in the staging and prognosis of patients with breast cancer.
    Horobin JM; Browning MC; McFarlane NP; Smith G; Preece PE; Wood RA; Cuschieri A
    J R Coll Surg Edinb; 1991 Aug; 36(4):219-21. PubMed ID: 1941734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer subtypes predispose the site of distant metastases.
    Soni A; Ren Z; Hameed O; Chanda D; Morgan CJ; Siegal GP; Wei S
    Am J Clin Pathol; 2015 Apr; 143(4):471-8. PubMed ID: 25779997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha2-globulins in breast carcinoma.
    Minton JP; Bianco MA
    Arch Surg; 1974 Aug; 109(2):238-40. PubMed ID: 4136177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
    Murayama Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer and clinical utility of CA 15-3 and CEA.
    Jäger W; Krämer S; Palapelas V; Norbert L
    Scand J Clin Lab Invest Suppl; 1995; 221():87-92. PubMed ID: 7652494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleuropulmonary metastases of female cancers].
    Lemarié E; Milleron B
    Rev Pneumol Clin; 1999 Oct; 55(5):271-9. PubMed ID: 10637893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca 15-3 in the follow-up of localised breast cancer: a prospective study.
    Kokko R; Holli K; Hakama M
    Eur J Cancer; 2002 Jun; 38(9):1189-93. PubMed ID: 12044504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CA 15.3 and early diagnosis of recurrence in breast cancer].
    Basuyau JP; Brunelle P; Charrot P; Chevallier B; Delapierre F; Graic Y; Julien JP; Veyret C
    Bull Cancer; 1993 Mar; 80(3):213-8. PubMed ID: 8173173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Jpn J Clin Oncol; 1997 Jun; 27(3):135-9. PubMed ID: 9255266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated serum levels of interleukin-6 in breast cancer patients with visceral metastases: preliminary report].
    Abe M; Ouchi N; Harada Y; Mori S; Rikiishi H; Kumagai K
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):107. PubMed ID: 1549091
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast carcinoma: pattern of metastasis at autopsy.
    Lee YT
    J Surg Oncol; 1983 Jul; 23(3):175-80. PubMed ID: 6345937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
    Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.